Accuracy of Core Body Temperature Measurement Depending on Oesophageal Probe Tip Location (ESO-TIP)

August 5, 2025 updated by: Institute of Mountain Emergency Medicine

Background An accurate measurement of the core body temperature (CBT) is of pivotal importance in the management of severely hypothermic patients. For instance, triage decisions for or against extracorporeal rewarming of hypothermic patients in cardiac arrest strongly depend on CBT. CBT measurement with an oesophageal probe is currently considered the gold standard in hypothermic patients with a secured airway in the prehospital setting, with the tip of the probe placed into the distal third of the oesophagus (i.e., posteriorly to the heart and distal to the tracheal bifurcation). However, the correct placement of the probe tip cannot be verified in the prehospital setting, and it is unknown how incorrect placement affects temperature readings.

Hypothesis and aim The investigators hypothesise that an incorrect placement of the oesophageal temperature probe tip could lead to inaccurate measurements (i.e., temperature readings not reflecting the real CBT). Particularly, a tip location too high in the oesophagus in close proximity to the trachea could lead to falsely low temperature readings, especially when the patient is ventilated with cold air. The aim of the proposed study is to investigate the influence of oesophageal temperature probe tip location on CBT measurement.

Methods Experimental, interventional study on 16 healthy volunteers. During the test oesophageal temperature is measured while participants are breathing ambient air first at 20°C (baseline) followed by cold (-20°C) ambient air in supine position for 20 minutes each test in an environmental simulator (terraXcube). Each participant repeats the 20-min test two times with the oesophageal temperature probe tip placed either in the lower third of the oesophagus (i.e., correct position) or too high in the oesophagus, i.e. behind the trachea.

Study Overview

Status

Completed

Study Type

Interventional

Enrollment (Actual)

15

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bolzano, Italy
        • terraXCube

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Volunteers with an American Society of Anaesthesiologists (ASA) score ≤2.

Exclusion Criteria:

  • ASA >3
  • Age < 18 and age >75
  • Pregnant women
  • No signed informed consent
  • Signs and symptoms of an acute illness on the study day
  • History of oesophageal and nasopharyngeal disorders
  • Allergies to Local Anaesthetics (i.e. Lidocain).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Correctly placed oesophageal probe at +20 degrees celsius ambient temperature
Oesophageal probe tip located in the lower third of the oesophagus, i.e. behind the left atrium, +20°C ambient temperature, outside terraXcube
Oesophageal temperature measurement
Experimental: Oesophageal probe tip too high at +20 degrees celsius ambient temperature
Oesophageal probe tip located too high the oesophagus, i.e. behind the trachea, 1-2 cm above the level of the tracheal bifurcation, +20°C ambient temperature, outside terraXcube
Oesophageal temperature measurement
Active Comparator: Correctly placed oesophageal probe at -20 degrees celsius ambient temperature
Oesophageal probe tip located in the lower third of the oesophagus, i.e. behind the left atrium, -20°C ambient temperature, inside terraXcube
Oesophageal temperature measurement
Experimental: Oesophageal probe tip too high at -20 degrees celsius ambient temperature
Oesophageal probe tip located too high the oesophagus, i.e. behind the trachea, 1-2 cm above the level of the tracheal bifurcation, -20°C ambient temperature, inside terraXcube
Oesophageal temperature measurement

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in core body temperature between the two tip positions
Time Frame: 20 minutes after cold air exposure
Difference in core body temperature between the two tip positions (i.e. in the lower third of the oesophagus (behind the left atrium) and in the middle third of the oesophagus (behind the trachea)
20 minutes after cold air exposure

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Simon Rauch, MD, PhD, Institute of Mountain Emergency Medicine, EURAC Research

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 23, 2024

Primary Completion (Actual)

December 31, 2024

Study Completion (Actual)

December 31, 2024

Study Registration Dates

First Submitted

April 11, 2024

First Submitted That Met QC Criteria

April 16, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Actual)

August 8, 2025

Last Update Submitted That Met QC Criteria

August 5, 2025

Last Verified

August 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • ESO-TIP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Emergencies

Clinical Trials on Oesophageal temperature measurement

Subscribe